There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...

Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

Enlivex (ENLV) has released an update. Enlivex Therapeutics has commenced the next phase of its Allocetra trial, enrolling and dosing the first ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

The Food and Drug Administration (FDA) has granted Fast Track designation to GNSC-001 for the treatment of osteoarthritis of the knee. GNSC-001 is an investigational, adeno-associated virus gene ...

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...

Recent clinical studies have revealed groundbreaking developments in treating knee osteoarthritis through metabolic ...

Once-weekly semaglutide shows significant reduction in knee osteoarthritis pain and body weight in adults with obesity, a ...

"Some patients who undergo successful surgery are unfortunately left with ongoing pain which can also be treated in this way.

The ‘Ozempic drug,’ semaglutide, has been found to reduce moderately severe pain caused by knee osteoarthritis and improve ...